| Code | CSB-RA751251MB2HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is designed as a research-grade biosimilar to BAY-1905254, targeting ILDR2 (Immunoglobulin-Like Domain Containing Receptor 2). ILDR2 is a transmembrane protein that plays a critical role in lipid metabolism and cellular lipid homeostasis, particularly in the regulation of triglyceride-rich lipoprotein uptake. This protein is expressed in various tissues including liver, intestine, and adipose tissue, where it influences metabolic processes. ILDR2 has emerged as a potential therapeutic target in metabolic disorders, including dyslipidemia and non-alcoholic fatty liver disease, as well as in certain cancers where aberrant lipid metabolism contributes to disease progression.
BAY-1905254 represents a research tool antibody developed for investigating ILDR2 function and its involvement in metabolic pathways. This biosimilar antibody provides researchers with a cost-effective alternative for studying ILDR2 expression patterns, protein interactions, and its role in lipid-related cellular processes. The antibody serves as a valuable reagent for exploring ILDR2 as a biomarker or therapeutic target in metabolic disease research and oncology studies.
There are currently no reviews for this product.